Merck's Vytorin cholesterol drug was found to reduce risks for heart attack, stroke and other cardiovascular events in the IMPROVE-IT study, which involved more than 18,000 patients with acute coronary syndrome.
Vytorin (Combination of Zetia and Simvastatin) May Help Lower LDL Cholesterol Levels: Study
Tech Times - 18 Nov 2014 14:45
Merck's Vytorin cholesterol drug was found to reduce risks for heart attack, stroke and other cardiovascular events in the IMPROVE-IT study, which involved more than 18,000 patients with acute coronary syndrome.
Share this Article
Recommended